Ziprasidone Intramuscular Injection Suppliers & Bulk Manufacturers

Available Forms: Intramuscular Injection (IM)

Available Strengths: 20 mg/mL

Reference Brands: Zeldox®(EU); Geodon®(US)

Category: Antipsychotropic Drugs

Ziprasidone Intramuscular Injection is available in Intramuscular Injection (IM) and strengths such as 20 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Ziprasidone Intramuscular Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Ziprasidone Intramuscular Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Ziprasidone intramuscular injection (brand name: Geodon) is FDA-approved in the United States for the acute treatment of agitation in patients with schizophrenia. It is intended for short-term use when rapid control of symptoms is clinically necessary. In the European Union, it is approved under the name Zeldox for similar indications. Regulatory approval requires GMP-compliant injectable manufacturing, validated safety and efficacy data, and pharmacokinetic studies supporting rapid onset. U.S. labeling includes warnings for QT interval prolongation and cardiac risk. EU approvals require Risk Management Plans (RMPs) and ongoing pharmacovigilance. For sourcing and dossier-ready options, visit Pharmatradz.com.